抑制心冠病毒的药要出来了吗？

重大信息--Sorrento Therapeutics  (SRNE) shares as much as doubled as the biopharma company said it was zeroing in on a potential breakthrough drug to treat the coronavirus. The San Diego biopharma said in a statement that in laboratory research, a new treatment provides "100%  inhibition" of SARS-CoV-2.

CEO Henry Ji 是个中国人。今天此股大涨，翻1.5倍，因为CEO说了这句话。如果是真的，拿是不是买航空游轮股的好时机？

As of 5/15/2020, NCLH: $11.11; CCL: $12.97; DAL: $19.41; LUV: $24.14;